glp 1 agonist new Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide Receptor Agonists: A Scoping Review Five Unexpected New Uses for
Description
Introduced around the 2000s, these drugs have opened new avenues in weight management strategies, heralding a paradigm shift in obesity treatment

60 In a functional human beta-cell line, it demonstrated a dose-dependent increase in insulin secretion

As GLP-1Rs are expressed in multiple brain regions, and GLP-1RAs such as liraglutide and lixisenatide can penetrate the blood-brain barrier, liraglutide and exendin-4 can be vagus-dependent or independent in the suppression of the food intake (176)

J Clin Endocrinol Metab 37, 826828 (1973)

Retatrutides manufacturers are studying the drugs effects on weight loss and knee pain from osteoarthritis, and early results indicate positive effects

References Bailey RA, Wang Y, Zhu V, Rupnow MFT
